Skip to main content
Research areas

Health and Biotechnology

microglia cells

Overview

The skills of chemical engineers are uniquely suited to developing next-generation solutions to persistent health challenges. UW ChemE boasts strong cross-disciplinary collaborations with medical researchers in the design of smarter therapeutics, targeted drug delivery systems, and improved diagnostics. Our faculty also conduct research in systems and synthetic biology, as well as metabolic, biomolecular, and protein engineering.

Research topics

  • Regenerative medicine
  • Neuromedicine
  • Nanomedicine
  • Metabolic engineering
  • Synthetic biology
  • Systems biology
  • Biomolecular engineering
  • Protein engineering
  • Environmental engineering
  • Medical diagnostics
  • Sensing technologies

Featured research clusters

Biomaterials

Faculty: Baneyx, DeForest, Nance, Ratner, Posner, Pozzo
With several field-defining visionaries in the biomedical sciences having cultivated their careers in UW ChemE, our department holds one of the longest and richest histories in biomaterial innovation. With creativity more fervent than ever, we employ current tools to engineer functional tissue, guide immune responses to medical implants, and probe stem cell fate in 4D.

Synthetic biology

Faculty: Bagheri, Beck, Carothers, DeForest, Marchand
Deciphering, retooling, and reinventing the tricks of basic biology, our faculty engineer versatile approaches to synthesize industrially and medically important chemicals and materials at scale. These efforts are complemented with advanced computational modeling to shed light on the inner workings of cellular bioprocesses.

Advanced therapeutic delivery

Faculty: DeForest, Nance, Ratner, Pozzo
From coercing nanoparticles past the blood-brain barrier, to identifying and treating disease with ultrasound theranostics, to confining therapeutic payload delivery to tissue-barcoded bodily locations, the University of Washington is developing real-world solutions to advance medical treatment. Studies are performed in close collaboration with field-leading partners in UW Medicine, Fred Hutch Cancer Research Center, and Seattle Children’s Hospital.

Campus opportunities

  • Institute for Stem Cell and Regenerative Medicine
    ISCRM's mission is to turn fundamental discoveries in stem cell science into therapies for patients
  • Center for Dialysis Innovation
    CDI develops and tests novel treatment technologies in order to improve the health and well-being of people receiving dialysis therapy
  • Institute for Protein Design
    The institute develops and applies methods for designing a whole new world of synthetic proteins to address today's complex challenges
  • Center for Synthetic Biology
    The center's mission is to provide a collaborative and interdisciplinary environment for research, education, innovation, safety and responsibility in synthetic biology at the UW and in the Seattle area
  • Hollomon Health Innovation Challenge
    The Hollomon Health Innovation Challenge is an entrepreneurship competition run by the UW Foster School of Business that gives students the opportunity to come up with meaningful solutions to big problems the world faces today related to health

Learn more

Related News

Kuleana logo

Fri, 10/24/2025 | UW Bioengineering

Ratner earns NIH tech transfer grant to improve dialysis for patients

Buddy Ratner earns a $1.6 million grant that will support a new method of recycling dialysate that is 500 times more efficient than current approaches.

A diagram showing three theoretical biomarkers that are present in specific, sometimes overlapping areas of the body.

Thu, 10/09/2025 | UW News

Programmable proteins use logic to improve targeted drug delivery

By adding smart tail structures to therapeutic proteins, researchers in the Deforest Lab demonstrated that the proteins could be “programmed” to act based on the presence of specific environmental cues.

Researcher pointing at visual data on a computer screen

Thu, 09/25/2025 | UW Medicine | Newsroom

Protein switches may lead to safer, smarter medicines

Adam Broerman, a chemical engineering Ph.D. student in the Baker Lab, is leading new research to potentially control when drugs are active or inactive in the body, making medicines smarter and safer.

Illustrated figure of curcumin-loaded nanoparticle targeting inflammation in the brain of fetal growth restricted pigs

Tue, 09/02/2025

A stable, scalable treatment for newborn brain injury

ChemE graduate student Nuo Xu (Ph.D. '25) has formulated shelf-stable therapeutics that have shown success treating brain injuries in newborn piglets, a promising step toward future clinical trials to treat brain injuries in human infants.